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The first Cardiac Emergency Room (CER) was founded in
1978 by Professor Dirk Durrer in Amsterdam. CERs have
since then been opened in many countries, with the initial goal
of reducing time delays in patients with acute myocardial
infarction. In this role they have contributed to the re-
ductions in mortality from coronary disease that have
been observed in the past decades [1]. In later years, the
focus of CERs has gradually shifted towards ruling out
acute coronary syndromes (ACS), to reduce unnecessary
hospital admissions [2].
In more recent years, other clinical conditions have
been added to the case loads of CERs, including worsen-
ing heart failure, atrial fibrillation and syncope. This is the
consequence of, among other things, increasing numbers
of patients who have survived a previous cardiac event, of
reduced capacity at outpatient clinics, of uncertainty
among general practitioners and of lower thresholds for
self-referral by well-informed patients. As a result, CERs
in many centres are receiving growing numbers of pa-
tients. Daily challenges are therefore increasingly logistic
in nature. One of the undesirable effects is that the goals
of CER staff may shift from understanding a patient’s
complaints and providing appropriate care to early dis-
charge and the creation of vacancy.
The study byWillems et al., published in this issue [3], was
performed against this background. The authors investigated a
new rule-out protocol that was aimed at early discharge of
patients presenting with chest pain who are at low risk of
serious adverse events. This risk was assessed by a number
of clinical characteristics (combined in the ‘Heart Score’), and
by ruling out myocardial damage as measured by ‘high
sensitive’ troponin T in plasma, at three time points after the
onset of symptoms.
As expected, both clinical parameters of risk and evi-
dence of myocardial damage were associated with in-
creased risk of adverse events in the first month following
discharge from the CER. Similarly expected, ‘high sensi-
tive’ troponin T had higher sensitivity for detection of
myocardial damage than the conventional troponin T assay
(both by Roche Diagnostics). In patients who were classi-
fied as low risk by both clinical and biochemical charac-
teristics, early discharge with outpatient clinical follow-up
appeared to be safe. This is consistent with previous
studies on comparable approaches [4]. Thus, the approach
described in this paper may assist clinical decision making
and support effective use of the CER, as the authors
suggest. In most CERs high sensitive troponin has now
replaced earlier assays of myocardial damage. The findings
of the current and similar studies may therefore be widely
used to guide clinical practice.
The quality of the current study is mainly limited by the
low number of patients that were included. For a reliable
estimate of the clinical outcome of major adverse cardiac
events, the observation would need to be about 100-fold larger
than the 89 patients in the present study. Second, one of the
most important components of the clinical assessment at the
CER is the nature of the presenting complaint. ‘Chest pain’ is
an ambiguous qualification of the patients’ presenting symp-
toms. The nature of the presenting complaint is included in the
assessment in the current study, as one of the components of
the ‘Heart Score’. However, it is reduced to a value of zero, 1
or 2 depending on how ‘typical’ the symptoms are. Careful
history taking by an experienced clinician will likely classify
many patients correctly by history alone, both in diagnostic
and prognostic terms. This is supported by good evidence in
patients with stable chest pain. Little evidence is available on
patients presenting with chest pain at rest, and it is clear that
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history alone is not sufficient to classify a patient’s risk.
Importantly, up to 20 % of patients with ACS have atypical
chest pain and a nondiagnostic electrocardiogram [5]. Still,
most seasoned clinicians would agree that diagnostic testing
cannot replace a careful history. In addition, without an un-
derstanding of clinical presentation the interpretation of the
results of laboratory tests may lead to serious error. It is
unfortunate, therefore, that recently published decision trees
start from the artificially uniform entry term of ‘chest pain’
[6]. Third, drug therapy after discharge or after admission was
not reported in the study. Clearly, with appropriate medication
the risk of adverse events during follow-up will be lower than
with insufficient medication, both after discharge and after
admission. Finally, noninvasive imaging or functional (stress)
testing is not included in the present study. Stress testing is
safe, with careful patient selection, and provides valuable
information to support the management of patients who pres-
ent with chest pain [7]. The potential value of recent imaging
modalities has been demonstrated and needs to be considered
when designing new rule-out protocols [8].
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